Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Fierce Pharma
Cidara snares BARDA award to boost R&D, production of flu asset
Cidara Therapeutics has secured federal backing to develop and produce its experimental flu preventive, dubbed CD388, in the U.S.
Fraiser Kansteiner
Oct 3, 2025 10:10am
ARPA-H data chief departs over mRNA vax cancellations
Aug 12, 2025 12:15pm
Vaxart seeks answers as BARDA vaccine funding dries up again
Aug 12, 2025 5:08am
Federal mRNA vax grant cuts includes unrelated project
Aug 7, 2025 2:20pm
HHS cancels mRNA vaccine development funded by BARDA
Aug 5, 2025 7:20pm
Basilea secures $39M as part of BARDA antifungal funding plan
Jul 8, 2025 3:52am